Preparation and Stability Evaluation of Flexible Nanoliposomes Co-Encapsulated with Black Wolfberry Anthocyanins and EGCG
LWT,
Год журнала:
2025,
Номер
unknown, С. 117402 - 117402
Опубликована: Янв. 1, 2025
Язык: Английский
Cyclodextrin-Based Drug Delivery Systems for Depression: Improving Antidepressant Bioavailability and Targeted Central Nervous System Delivery
Renata Maria Văruț,
Alin Iulian Silviu Popescu,
Simina Găman
и другие.
Pharmaceutics,
Год журнала:
2025,
Номер
17(3), С. 355 - 355
Опубликована: Март 10, 2025
Cyclodextrin
(CD)-based
drug
delivery
systems
have
emerged
as
a
promising
strategy
to
overcome
limitations
commonly
encountered
in
antidepressant
therapy,
including
low
bioavailability,
poor
solubility,
and
suboptimal
penetration
of
the
blood–brain
barrier.
This
review
synthesizes
current
evidence
demonstrating
that
complexing
various
classes
antidepressants—such
tricyclic
antidepressants
(TCAs),
selective
serotonin
reuptake
inhibitors
(SSRIs),
atypical
antidepressants—with
β-CD
or
its
derivatives
significantly
enhances
solubility
stability.
In
addition,
encapsulation
with
CDs
can
diminish
systemic
toxicity
improve
pharmacokinetics,
thereby
helping
optimize
dosage
regimens
reduce
adverse
effects.
Analysis
published
vitro
vivo
studies
indicates
CD
formulations
not
only
boost
therapeutic
efficacy
but
also
enable
sustained
targeted
release,
which
is
critical
for
drugs
requiring
precise
plasma
tissue
concentrations.
When
compared
other
carriers
(e.g.,
liposomes,
polymeric
nanoparticles,
dendrimers),
CD-based
often
stand
out
their
ease
formulation,
biocompatibility,
cost-effectiveness,
although
limited
drug-loading
capacity
be
drawback.
We
recommend
expanding
trials
substantiate
clinical
benefits
CD–antidepressant
complexes,
particularly
treatment-resistant
cases
specific
subpopulations
elderly
pediatric
patients).
Additional
investigations
should
explore
hybrid
systems—combining
advanced
nano-
macroparticles—to
amplify
advantages
address
any
limitations.
Ultimately,
integrating
into
holds
substantial
potential
refine
therapy
outcomes,
events,
pave
way
more
personalized,
effective
interventions
depression.
Язык: Английский
Insights into Liposomal and Gel-Based Formulations for Dermatological Treatments
Gels,
Год журнала:
2025,
Номер
11(4), С. 245 - 245
Опубликована: Март 26, 2025
Dermatological
diseases
pose
a
significant
challenge
due
to
their
chronic
nature,
complex
pathophysiology,
and
the
need
for
effective,
patient-friendly
treatments.
Recent
advancements
in
liposomal
gel-based
formulations
have
played
crucial
role
improving
drug
delivery,
therapeutic
efficacy,
patient
compliance.
Liposomal
garnered
considerable
attention
dermatology
ability
encapsulate
both
hydrophilic
lipophilic
compounds,
enabling
controlled
release
enhanced
skin
penetration.
However,
challenges
such
as
formulation
complexity,
stability
issues,
regulatory
constraints
remain.
Similarly,
are
widely
used
ease
of
application,
biocompatibility,
retain
active
ingredients.
they
also
face
limitations,
including
restricted
penetration
depth,
susceptibility
microbial
contamination,
achieving
sustained
release.
The
integration
technologies
offers
promising
strategy
overcome
current
optimize
dermatological
delivery.
This
review
explores
well-established
therapies
recent
innovations,
offering
comprehensive
overview
applications
treatment
prevalent
conditions.
Ultimately,
continued
research
is
essential
refine
these
formulations,
expanding
clinical
utility
enhancing
effectiveness
dermatology.
Язык: Английский